Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy.

Y Baek(Showa University Fujigaoka Hospital), Masato Yamaguchi(Jikei University School of Medicine), Hiroyuki Nakano(Osaka Medical and Pharmaceutical University), Takemasa Midorikawa, Masuo Kaneda, N. Kitamura, Kazuki Kumada(Tohoku University), Gaku Kigawa, Junichi Sasaki(Institute for Atherosclerosis Research), T Hatakeyama, Hideaki Nagasaki, Yoshinori Sanada
PubMed
September 22, 1999
Cited by 12

Related Papers

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
|Journal of Atherosclerosis and Thrombosis|2013|469
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
Idiopathic Pulmonary Fibrosis. Epidemiologic Approaches to Occupational Exposure
|American Journal of Respiratory and Critical Care Medicine|1994|269
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Characterization of EP receptor subtypes responsible for prostaglandin E<sub>2</sub>‐induced pain responses by use of EP<sub>1</sub> and EP<sub>3</sub> receptor knockout mice
|British Journal of Pharmacology|2001|181